Company profile

Ticker
AVTR, AVTR+A
Exchange
CEO
Michael Stubblefield
Employees
Incorporated
Location
Fiscal year end
Former names
Vail Holdco Corp
SEC CIK

AVTR stock data

(
)

Calendar

27 Oct 20
5 Dec 20
31 Dec 20

News

Quarter (USD) Sep 20 Jun 20 Mar 20 Sep 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Avantor earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
10 Nov 20 New Mountain Investments III Common Stock Sell Dispose S No 24.8081 36,016,093 893.49M 28,000,000
5 Oct 20 Ohri Devashish Common Stock Sell Dispose S Yes 23.34 50,000 1.17M 151,671
5 Oct 20 Ohri Devashish Common Stock Option exercise Aquire M No 1.6 50,000 80K 201,671
5 Oct 20 Ohri Devashish Common Stock Sell Dispose S Yes 23.47 35,000 821.45K 151,671
5 Oct 20 Ohri Devashish Common Stock Option exercise Aquire M No 1.6 35,000 56K 186,671
5 Oct 20 Ohri Devashish Common Stock Sell Dispose S Yes 23.53 18,440 433.89K 151,671
5 Oct 20 Ohri Devashish Common Stock Option exercise Aquire M No 1.6 18,440 29.5K 170,111
5 Oct 20 Ohri Devashish Stock Options Common Stock Option exercise Dispose M No 1.6 50,000 80K 100,160
5 Oct 20 Ohri Devashish Stock Options Common Stock Option exercise Dispose M No 1.6 35,000 56K 150,160
5 Oct 20 Ohri Devashish Stock Options Common Stock Option exercise Dispose M No 1.6 18,440 29.5K 0
84.8% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 318 264 +20.5%
Opened positions 83 117 -29.1%
Closed positions 29 25 +16.0%
Increased positions 140 91 +53.8%
Reduced positions 66 39 +69.2%
13F shares
Current Prev Q Change
Total value 14.88B 8.98B +65.7%
Total shares 490.16M 479.55M +2.2%
Total puts 880.8K 286.6K +207.3%
Total calls 1.33M 620.1K +114.3%
Total put/call ratio 0.7 0.5 +43.4%
Largest owners
Shares Value Change
New Mountain Vantage Advisers, L.L.C. 64.02M $1.44B -28.5%
TROW T. Rowe Price 51.42M $1.16B -17.5%
GS Goldman Sachs 45.34M $1.02B -28.5%
Vanguard 39.88M $896.83M +10.0%
BLK Blackrock 29.77M $669.48M +14.4%
IVZ Invesco 28.94M $650.94M +12.8%
Nuveen Asset Management 25.2M $566.76M +33.8%
Boston Partners 19.01M $427.43M +9.0%
American Century Companies 15.54M $349.44M -4.0%
Brown Brothers Harriman & Co 9.14M $205.61M -0.0%
Largest transactions
Shares Bought/sold Change
New Mountain Vantage Advisers, L.L.C. 64.02M -25.58M -28.5%
GS Goldman Sachs 45.34M -18.11M -28.5%
TROW T. Rowe Price 51.42M -10.89M -17.5%
Palestra Capital Management 6.84M +6.84M NEW
Nuveen Asset Management 25.2M +6.37M +33.8%
Third Point 5M +5M NEW
BLK Blackrock 29.77M +3.76M +14.4%
Vanguard 39.88M +3.63M +10.0%
Maverick Capital 1.48M -3.56M -70.7%
IVZ Invesco 28.94M +3.28M +12.8%

Financial report summary

?
Competition
KMG Chemicals
Risks
  • Significant interruptions in our operations could harm our business, financial condition and results of operations.
  • We compete in highly competitive markets. Failure to compete successfully could adversely affect our business, financial condition and results of operations.
  • It may be difficult for us to implement our strategies for improving growth.
  • Part of our growth strategy is to pursue strategic acquisitions, which will subject us to a variety of risks that could harm our business.
  • We may not be able to integrate mergers or acquisitions successfully into our existing business, or realize anticipated cost savings or synergies, if any, from those transactions, which could adversely affect our business.
  • Our business, financial condition and results of operations may be harmed if our customers discontinue or spend less on research, development, production or other scientific endeavors.
  • The customers we serve have and will continue to experience significant industry-related changes that could adversely affect our business.
  • We may be adversely affected by global and regional economic and political conditions.
  • The United Kingdom’s decision to leave the European Union (“Brexit”) could adversely affect our business.
  • Our offerings are highly complex, and, if our products do not satisfy applicable quality criteria, specifications and performance standards, we could experience lost net sales, delayed or reduced market acceptance of our products, increased costs and damage to our reputation.
  • The loss of a significant number of customers or a reduction in orders from a significant number of customers could reduce our net sales and harm our operating results.
  • We are subject to risks associated with doing business globally, which may harm our business.
  • Changes in exchange rates can adversely affect our net sales, profits and cash flows.
  • Our business depends on our ability to use and access information systems, and any failure to successfully maintain these systems or implement new systems to handle our changing needs could materially harm our operations.
  • Our inability to protect our intellectual property could adversely affect our business. In addition, third parties may claim that we infringe their intellectual property, and we could suffer significant litigation or licensing expenses as a result.
  • Our trademarks are valuable assets and if we are unable to protect them from infringement our business prospects may be harmed.
  • We are subject to product liability and other claims in the ordinary course of business.
  • We must develop new products, adapt to rapid and significant technological change and respond to introductions of new products by competitors to remain competitive.
  • Our business, financial condition and results of operations depend upon the availability of raw materials.
  • Our business, financial condition and results of operations depend upon maintaining our relationships with suppliers.
  • Our use of chemicals and chemical processes is subject to inherent risk.
  • We are highly dependent on our senior management and key employees. Competition for our employees is intense, and we may not be able to attract and retain the highly skilled employees that we need to support our business and our intended future growth.
  • We may incur impairment charges on our goodwill, other intangible assets or other assets that would reduce our earnings.
  • Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.
  • The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
  • Government or private civil antitrust actions could harm our business, results of operations, financial condition and cash flows.
  • Changes in tax law relating to multinational corporations could adversely affect our tax position.
  • Certain of our businesses rely on relationships with collaborative partners and other third parties for development, supply and marketing of certain products and potential products, and such collaborative partners or other third parties could fail to perform sufficiently.
  • We are required to comply with a wide variety of laws and regulations, and are subject to regulation by various federal, state and foreign agencies, and our failure to comply with existing and future regulatory requirements could adversely affect our results of operations and financial condition.
  • Violation of government regulations or quality programs could harm demand for our products or services.
  • We are subject to environmental, health and safety laws and regulations, and costs to comply with such laws and regulations, or any liability or obligation imposed under such laws or regulations, could negatively impact our business, financial condition and results of operations.
  • Our substantial indebtedness could adversely affect our financial condition and prevent us from fulfilling our debt or contractual obligations.
  • Our debt agreements contain restrictions on our ability to operate our business and to pursue our business strategies, and our failure to comply with, cure breaches of, or obtain waivers for covenants could result in an acceleration of the due date of our indebtedness.
  • Despite our current level of indebtedness, we and our subsidiaries may still be able to incur substantially more debt.
  • We may be unable to generate sufficient cash flow to satisfy our significant debt service obligations, which could have a material adverse effect on our business, financial condition and results of operations.
  • An increase in interest rates may negatively impact our operating results and financial condition.
  • Our ability to repay our indebtedness is affected by the cash flow generated by our subsidiaries.
  • Our stock price may be volatile or may decline regardless of our operating performance, and you may not be able to resell shares of our common stock at or above the price you paid or at all, and you could lose all or part of your investment as a result.
  • The outstanding shares of MCPS may adversely affect the market price of our common stock.
  • Certain rights of the holders of the MCPS could delay or prevent an otherwise beneficial takeover or takeover attempt of us.
  • Our common stock ranks junior to the MCPS with respect to the payment of dividends and amounts payable in the event of our liquidation, dissolution or winding-up of our affairs.
  • Holders of the MCPS have the right to elect two directors in the case of certain dividend arrearages.
  • Because we have no current plans to pay cash dividends on our common stock, you may not receive any return on investment unless you sell your common stock for a price greater than that which you paid for it.
  • We are a holding company with no operations of our own and, as such, we depend on our subsidiaries for cash to fund all of our operations and expenses, including future dividend payments, if any.
  • If securities or industry analysts do not publish research or reports about our business or if they downgrade our stock or our sector, our stock price and trading volume could decline.
  • Maintaining the requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain qualified board members.
  • Future sales, or the perception of future sales, by us or our existing stockholders in the public market could cause the market price for our common stock to decline.
  • Concentrations of shareholder control could have adverse impacts
  • Anti-takeover provisions in our organizational documents could delay or prevent a change of control.
  • Our Board of Directors is authorized to issue and designate shares of our preferred stock in additional series without stockholder approval.
  • Our amended and restated certificate of incorporation provides, subject to limited exceptions, that state and federal courts (as appropriate) located within the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or stockholders.
Management Discussion
  • We present results of operations in the same way that we manage our business, evaluate our performance and allocate our resources. We also provide discussion of net sales and Adjusted EBITDA by geographic segment based on customer location: Americas, Europe and AMEA. Corporate costs are managed on a standalone basis and not allocated to segments.
  • Third quarter revenue growth reflects strong growth in the biopharma and healthcare end markets and COVID-19 related sales of PPE and solutions to support diagnostic testing and vaccine development. Double-digit growth of our proprietary materials and consumables product group, commercial excellence, and continued impact of productivity and cost containment contributed to Adjusted EBITDA margin expansion.
  • Net sales increased $101.2 million or 6.7%, which included $20.7 million or 1.3% of favorable foreign currency impact. The increase in organic net sales of $80.5 million or 5.4% was due to growth in our ongoing business as well as to COVID-19 related sales.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: August, began, chromatography, closure, content, dealt, deconsolidation, denominated, drove, examination, exposed, finalizing, forward, inversely, match, perfectly, PPE, principal, pronounced, refinance, released, return, roughly, spot, vaccination, vaccine, worth
Removed: accumulation, challenging, contraction, low, research